White matter microstructure and its relation to clinical features of obsessive-compulsive disorder: findings from the ENIGMA OCD Working Group.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
17 03 2021
Historique:
received: 14 02 2020
accepted: 19 10 2020
revised: 15 06 2020
entrez: 18 3 2021
pubmed: 19 3 2021
medline: 29 6 2021
Statut: epublish

Résumé

Microstructural alterations in cortico-subcortical connections are thought to be present in obsessive-compulsive disorder (OCD). However, prior studies have yielded inconsistent findings, perhaps because small sample sizes provided insufficient power to detect subtle abnormalities. Here we investigated microstructural white matter alterations and their relation to clinical features in the largest dataset of adult and pediatric OCD to date. We analyzed diffusion tensor imaging metrics from 700 adult patients and 645 adult controls, as well as 174 pediatric patients and 144 pediatric controls across 19 sites participating in the ENIGMA OCD Working Group, in a cross-sectional case-control magnetic resonance study. We extracted measures of fractional anisotropy (FA) as main outcome, and mean diffusivity, radial diffusivity, and axial diffusivity as secondary outcomes for 25 white matter regions. We meta-analyzed patient-control group differences (Cohen's d) across sites, after adjusting for age and sex, and investigated associations with clinical characteristics. Adult OCD patients showed significant FA reduction in the sagittal stratum (d = -0.21, z = -3.21, p = 0.001) and posterior thalamic radiation (d = -0.26, z = -4.57, p < 0.0001). In the sagittal stratum, lower FA was associated with a younger age of onset (z = 2.71, p = 0.006), longer duration of illness (z = -2.086, p = 0.036), and a higher percentage of medicated patients in the cohorts studied (z = -1.98, p = 0.047). No significant association with symptom severity was found. Pediatric OCD patients did not show any detectable microstructural abnormalities compared to controls. Our findings of microstructural alterations in projection and association fibers to posterior brain regions in OCD are consistent with models emphasizing deficits in connectivity as an important feature of this disorder.

Identifiants

pubmed: 33731673
doi: 10.1038/s41398-021-01276-z
pii: 10.1038/s41398-021-01276-z
pmc: PMC7969744
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

173

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB015922
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Investigateurs

Francesca Assogna (F)
Rosa Calvo (R)
Stella J de Wit (SJ)
Morgan Hough (M)
Masaru Kuno (M)
Euripedes C Miguel (EC)
Astrid Morer (A)
Christopher Pittenger (C)
Sara Poletti (S)
Enrico Smeraldi (E)
João R Sato (JR)
Aki Tsuchiyagaito (A)
Susanne Walitza (S)
Ysbrand D van der Werf (YD)
Daniela Vecchio (D)
Mojtaba Zarei (M)

Références

J Psychiatry Neurosci. 2014 Sep;39(5):304-11
pubmed: 24866415
J Magn Reson B. 1996 Jun;111(3):209-19
pubmed: 8661285
Transl Psychiatry. 2017 Aug 29;7(8):e1224
pubmed: 28850108
Mol Psychiatry. 2020 Jul;25(7):1511-1525
pubmed: 31471575
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
Ann Neurol. 2004 Sep;56(3):407-15
pubmed: 15349868
Schizophr Res. 2015 Mar;162(1-3):22-8
pubmed: 25660467
J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52
pubmed: 9183141
Brain Behav. 2017 Jan 14;7(2):e00615
pubmed: 28239525
Neuroimage. 2017 Jan 15;145(Pt B):389-408
pubmed: 26658930
Neurosci Biobehav Rev. 2015 May;52:233-57
pubmed: 25766413
Mol Psychiatry. 2020 Nov;25(11):2818-2831
pubmed: 31358905
Brain Connect. 2011;1(6):423-46
pubmed: 22432902
Neuroimage. 2008 Apr 1;40(2):570-582
pubmed: 18255316
Arch Gen Psychiatry. 2004 Jul;61(7):720-30
pubmed: 15237084
Adolesc Psychiatry. 2005;29:55-96
pubmed: 18668184
Neuropsychopharmacology. 2014 Jun;39(7):1547-57
pubmed: 24407265
Am J Psychiatry. 2008 Oct;165(10):1308-15
pubmed: 18519525
Br J Psychiatry. 2010 Aug;197(2):128-34
pubmed: 20679265
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Neurobiol Dis. 2010 Feb;37(2):468-76
pubmed: 19913616
World Psychiatry. 2007 Oct;6(3):168-76
pubmed: 18188442
Am J Psychiatry. 2016 Sep 9;174(1):60-69
pubmed: 27609241
Dev Psychopathol. 2008 Fall;20(4):1251-83
pubmed: 18838041
JAMA Psychiatry. 2014 May;71(5):582-4
pubmed: 24671770
Trends Neurosci. 2008 Jul;31(7):361-70
pubmed: 18538868
Neuroimage. 2003 Nov;20(3):1714-22
pubmed: 14642481
Eur Neuropsychopharmacol. 2013 Jul;23(7):581-93
pubmed: 22954900
Biol Mood Anxiety Disord. 2012 Mar 08;2:6
pubmed: 22737993
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11
pubmed: 2684084
Front Psychiatry. 2019 May 10;10:319
pubmed: 31133898
Neuroimage Clin. 2016 Sep 28;12:1022-1034
pubmed: 27995068
Nat Rev Neurosci. 2015 Dec;16(12):756-67
pubmed: 26585800
Magn Reson Imaging. 2011 Jan;29(1):111-25
pubmed: 20933352
Transl Psychiatry. 2017 Mar 14;7(3):e1062
pubmed: 28291264
Nat Neurosci. 2019 Jun;22(6):992-999
pubmed: 31086316
J Psychiatr Res. 2014 Jul;54:26-35
pubmed: 24694669
Neuroimage. 2014 Jul 1;94:65-78
pubmed: 24650605
NMR Biomed. 2015 Mar;28(3):327-37
pubmed: 25639498
Mol Psychiatry. 2018 May;23(5):1261-1269
pubmed: 29038599
Nat Rev Neurosci. 2008 Dec;9(12):947-57
pubmed: 19002191
Am J Psychiatry. 2018 May 1;175(5):453-462
pubmed: 29377733
Glia. 2014 Nov;62(11):1856-77
pubmed: 25056210
Neuroscience. 2007 Apr 14;145(4):1426-38
pubmed: 17049173
Early Hum Dev. 2006 Apr;82(4):257-66
pubmed: 16360292
J Nerv Ment Dis. 2001 Jul;189(7):471-7
pubmed: 11504325
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2856-77
pubmed: 24177038
Neuropsychopharmacology. 2012 Nov;37(12):2730-9
pubmed: 22871914
Biol Mood Anxiety Disord. 2014 Dec 18;4(1):13
pubmed: 25540681
PLoS One. 2015 Jun 03;10(6):e0127118
pubmed: 26038825
Psychiatry Clin Neurosci. 2018 Jan;72(1):13-27
pubmed: 28815874

Auteurs

Fabrizio Piras (F)

Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy. f.piras@hsantalucia.it.

Federica Piras (F)

Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.

Yoshinari Abe (Y)

Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Sri Mahavir Agarwal (SM)

Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry, National Institute of Mental Health & Neurosciences, Bangalore, India.

Alan Anticevic (A)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Stephanie Ameis (S)

Child, Youth and Emerging Adult Program, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Department of Psychiatry, Hospital for Sick Children, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Paul Arnold (P)

Mathison Centre for Mental Health Research & Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Nerisa Banaj (N)

Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.

Núria Bargalló (N)

Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centre de Diagnostic per la Imatge (CDIC), Hospital Clínic de Barcelona, Barcelona, Spain.

Marcelo C Batistuzzo (MC)

Instituto e Departamento de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

Francesco Benedetti (F)

Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.

Jan-Carl Beucke (JC)

Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
K8 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Premika S W Boedhoe (PSW)

Amsterdam University Medical Centers, Vrije Universiteit, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Amsterdam university medical centers, Vrije Universiteit, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Irene Bollettini (I)

Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.

Silvia Brem (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

Anna Calvo (A)

Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Kang Ik Kevin Cho (KIK)

Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea.

Valentina Ciullo (V)

Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.

Sara Dallaspezia (S)

Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, Italy.

Erin Dickie (E)

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

Benjamin Adam Ely (BA)

Department of Neuroscience and Graduate School, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Siyan Fan (S)

Amsterdam university medical centers, Vrije Universiteit, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Jean-Paul Fouche (JP)

SAMRC Unit on Anxiety & Stress Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Patricia Gruner (P)

Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.

Deniz A Gürsel (DA)

Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, München, Germany.

Tobias Hauser (T)

Amsterdam university medical centers, Vrije Universiteit, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Yoshiyuki Hirano (Y)

Research Center for Child Mental Development, Chiba University, Chiba, Japan.

Marcelo Q Hoexter (MQ)

Instituto e Departamento de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

Mariangela Iorio (M)

Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.
Center of Excellence on Aging and Translational Medicine - CeSI-MeT, Chieti, Italy.

Anthony James (A)

Department of Psychiatry, Oxford University, Oxford, UK.

Y C Janardhan Reddy (YCJ)

Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry, National Institute of Mental Health & Neurosciences, Bangalore, India.

Christian Kaufmann (C)

Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
Department of Psychology, Freie Universität zu Berlin, Berlin, Germany.

Kathrin Koch (K)

Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, München, Germany.

Peter Kochunov (P)

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

Jun Soo Kwon (JS)

Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea.

Luisa Lazaro (L)

Department of Child and Adolescent Psychiatry and Psychology, Institute of Neurosciences, Hospital Clínic Universitari, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Christine Lochner (C)

SAMRC Unit on Anxiety & Stress Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Rachel Marsh (R)

Columbia University Irving Medical Center, Columbia University, New York, NY, USA.
The new York State Psychiatric Institute, New York, NY, USA.

Akiko Nakagawa (A)

Research Center for Child Mental Development, Chiba University, Chiba, Japan.

Takashi Nakamae (T)

Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Janardhanan C Narayanaswamy (JC)

Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry, National Institute of Mental Health & Neurosciences, Bangalore, India.

Yuki Sakai (Y)

Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Eiji Shimizu (E)

Research Center for Child Mental Development, Chiba University, Chiba, Japan.

Daniela Simon (D)

Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.

Helen Blair Simpson (HB)

Columbia University Irving Medical Center, Columbia University, New York, NY, USA.
The new York State Psychiatric Institute, New York, NY, USA.

Noam Soreni (N)

Pediatric OCD Consultation Clinic, Anxiety Treatment and Research Center, McMaster University, Hamilton, Ontario, Canada.

Philipp Stämpfli (P)

MR-Center of the Department of Psychiatry, Psychotherapy and Psychosomatics and the Department of Child and Adolescent Psychiatry, Psychiatric Hospital of the University of Zurich, Zurich, Switzerland.

Emily R Stern (ER)

Department of Neuroscience and Graduate School, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Philip Szeszko (P)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jumpei Takahashi (J)

Research Center for Child Mental Development, Chiba University, Chiba, Japan.

Ganesan Venkatasubramanian (G)

Obsessive-Compulsive Disorder (OCD) Clinic, Department of Psychiatry, National Institute of Mental Health & Neurosciences, Bangalore, India.

Zhen Wang (Z)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.

Je-Yeon Yun (JY)

Institute of Human Behavioral Medicine, SNU-MRC, Seoul, Republic of Korea.

Dan J Stein (DJ)

SAMRC Unit on Anxiety & Stress Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Neda Jahanshad (N)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, USA.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, USA.

Odile A van den Heuvel (OA)

Amsterdam University Medical Centers, Vrije Universiteit, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Amsterdam university medical centers, Vrije Universiteit, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Gianfranco Spalletta (G)

Laboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy. g.spalletta@hsantalucia.it.
Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA. g.spalletta@hsantalucia.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH